Antimicrobial resistance and molecular typing of Pseudomonas aeruginosa isolated from surgical wounds in Lagos, Nigeria

Acta Medica Iranica

Volumn 50, Issue 6, 2012, Pages 433-438

  Smith, Stella ^a   Ganiyu, Olaniyi ^b   John, Rachael ^b   Fowora, Muinah ^a   Akinsinde, Kehinde ^a   Odeigah, Peter ^b  

^a NIGERIAN INSTITUTE OF MEDICAL RESEARCH   (Nigeria)

^b UNIVERSITY OF LAGOS   (Nigeria)

Author keywords

Microbial sensitivity tests; Molecular typing; Pseudomonas aeruginosa

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFOXITIN; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; NITROFURANTOIN; OFLOXACIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLASSIFICATION; GYRA GENE; HOSPITAL; HUMAN; MOLECULAR TYPING; NIGERIA; NONHUMAN; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; RANDOM AMPLIFIED POLYMORPHIC DNA; WOUND;

HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; NIGERIA; PSEUDOMONAS AERUGINOSA; SURGICAL WOUND INFECTION;

EID: 84865696407     PISSN: 00446025     EISSN: 17359694     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Maksimovic, J., Markovic-Denic. L., Bumbasirevic. M., Marinkovic, J., Vlajinac, H. Surigcal site infections in orthopaedic patients: Prospective cohort study. Croat Med J 2008; 49: 58 - 65.
2. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of microbiology laboratory. Clin Microbiol Rev 1993; 6: 428 - 42.
3. Bertrand X, Thouverez M, Patry C, Balvay P, Talon D. Pseudomonas aeruginosa: antibiotic ausceptibility and genotypic characterization of strains isolated in the intensive care unit. Clin Microbiol Infect 2001; 7: 706 - 8.
4. Blanc DS, Francioli P, Zanetti G. Molecular epidemiology of Pseudomonas aeruginosa in the intensive care units-A Review. The Open Microbiol J 2007; 1: 8-11.
5. Brauner A, Cryz SJ, Granstrom M, Hanson HS, Lofstrand L, Strandvik B, Wretlind B. Immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharides and exotoxin A in patients with systic fibrosis or bacteraemia. Eur J Clin Microbiol Infect Dis 1993; 12: 420 - 36.
6. Odusanya OO. Antibiotic susceptibility of microorganisms at a General Hospital in Lagos, Nigeria. J Natl Med Assoc 2002; 94: 994 - 998.
7. Jombo GT, Jonah P, Ayeni JA. Multiple resistant Pseudomonas aeruginosa in contemporary medical practice:findings fromurinary isolates at a Nigerian University Teaching Hospital. Nig J Physiol Sci 2008; 23: 105 - 9.
8. Wariso BA, Ibe SN. Bacteriology of chronic discharging ears in Port Harcourt, Nigeria. W Afr J Med 2006; 25: 219 - 222.
9. de Freitas ALP, Barth AL. Antibiotic resistance and molecular typing of Pseudomonas aeruginosa: focus on imipenem. The Braz J Infect Dis 2002; 6: 1 - 7.
10. Panzig B, Schroder G, Grunding MA. A large outbreak of multiresistant Pseudomonas aeruignosa strains in north-eastern Germany. J Antimicrob Chemother 1999; 43: 415 - 8.
11. Tsakris A, Pournaras S, Woodsord N et al. Outbreak of infections caysed by Pseudomonas aeruginosa producing VIM-1 carbapanemase in Greece. J Clin Microbiol 2000; 38: 1290 - 2.
12. Sazakli E, Leotsinidis M, Vantarakis A, Papapetropoulou M. Comparative typing of Pseudomonas species isolaued from the aquatic envrionment in Greece by SDS-PAGE and RAPD analysis. J Appl Microbiol 2005; 99: 1191 - 1203.
13. National Committee for Clinical and Laboratory Standards Criteria. Analysis and presentation of cumulative antimicrobial susceptibility data. 2nd edition. Vol 7, M39-A2; 2005.
14. Birnboim HC, Doly JA. rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 1979; 97: 1513-1523.
15. Murakami K, Nomura K, Doi M, Yoshida T. Production of low-affinity penicillin binding protein by low and high resistance group of methicillin resistant Staphylococcus aureus. Antimicrob Agents Chemother 1987; 31: 1307 - 11.
16. Eftekhar F, Hosseinkhan N, Asgharadeh A, Tabatabaii A. Genetic profiling of Pseudomonas aeruginosa isolates from Iranian patients with cystic fibrosis using RAPD-PCR and PFGE. Iran J Basic Med Sci 2009; 12: 126 - 132.
17. Nikbin VS, Abdi-Ali A, Feizabadi MM, Gharavi S. Pulsed-field gel electrophoresis and plasmid profile of Pseudomonas aeruginosa at two hospitals in Tehran, Iran. Indian J Med Res 2007; 126: 146 - 51.
18. Tassios PT, Gennimata V, Maniatis AN, Fock C, Legakis NJ, and the Greek Pseudomonas aeruginosa Study Group. Emergence of multidrug resistance in ubiquitous and dominant Pseudomonas aeruginosa serogroup 0:11. J Clin Microbiol 1998; 36: 897 - 901.
19. Bouza E, Garcia-Garrote F, Cercenado E, Marin M, Diaz for the Spanish Pseudomonas aeruginosa Study Group. Pseudomonas aeruginosa: a survey of resistance in 136 hospitals in Spain. Antimicrob Agents Chemother 1999; 43: 981 -2.
20. Onipede AO, Onayade AA, Elusiyan JBE, et al. Invasive bacteria isolates from children with severe infections in a Nigerian hospital. J Infect Develop Countr 2009; 3: 429 - 36.
21. Fadeyi A, Akanbi AA 2nd, Nwabuisi C and Onile BA. Antibiotic disk sensitivity pattern of Pseudomonas aeruginosa isolates obtained from clinical specimens in Ilorin, Nigeria. Afr J Med Med Sci 2005; 34: 303 - 6.
22. Ogbolu DO, Ogunledun A, Adebiyi OE, Daini OA and Alli AO. Antibiotic susceptibility patterns of Pseudomonas aeruginosa to available antipseudomonal drugs in Ibadan, Nigeria. Afr J Medical Sci 2008; 37: 339 - 44.
23. Yoon MY, Lee K, Jeong SH, Kim J, Yoon SS. Heterogeneous virulence potential and high antibiotic resistance of Pseudomonas aeruginosa strains isolated from Korean pneumonia patients. J Microbiol 2010; 48: 518 - 25.